Equity Research, Broker Reports, and media content on Sanofi

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Sanofi
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Sanofi. We currently have 11 research reports from 1 professional analysts.

Open
82.7
Volume
0.3m
Range
82.5/83.3
Market Cap
104,390,401,845m
52 Week
66.7/93.0
Date Source Announcement
20Sep17 11:58 GNW Sanofi and Alnylam Report Positive Topline Results from APOLLO Phase 3 Study of Patisiran in Hereditary ATTR (hATTR) Amyloidosis Patients with Polyneuropathy
16Sep17 07:15 GNW Sanofi and Regeneron Announce Positive Study Results for Dupixent® (dupilumab) in Patients With Moderate-to-Severe Atopic Dermatitis
11Sep17 05:58 GNW Sanofi, Regeneron: Dupilumab Hits Main Objectives in Late-Stage Asthma Trial
08Sep17 05:58 GNW Sanofi, Regeneron: Cemiplimab Receives FDA Breakthrough Designation for Advanced Cutaneous Squamous Cell Carcinoma
07Sep17 12:03 GNW Sanofi Alliance Partner Alnylam Gives Update on Fitusiran
07Sep17 06:00 GNW Sanofi rated AA by Scope Ratings
28Aug17 06:00 GNW Sanofi completes the acquisition of Protein Sciences
  • Frequency of research reports

     

  • Research reports on

    Sanofi

  • Providers covering

    Sanofi